CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 7 enrolled
Drug / intervention
Naltrexone +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00467558
NCT00467558Phase 2Completed
CompareCT.gov

A Double-Blind, Placebo-Controlled Study of Naltrexone in Compulsive Sexual Behavior

University of Minnesota·interventional·Posted Apr 30, 2007·Updated May 18, 2012

In Brief

A Phase 2 clinical trial evaluating Naltrexone and Sugar pill for Compulsive Sexual Behavior. Completed, enrolled 7 participants across 1 site.

Detailed Summary

The goal of the proposed study is to evaluate the efficacy and safety of naltrexone in compulsive sexual behavior. Twenty subjects with DSM-IV compulsive sexual behavior will receive 8 weeks of naltrexone or placebo. The hypothesis to be tested is that naltrexone will be effective in reducing the urges to act out sexually in patients with compulsive sexual behavior. The proposed study will provide needed data on the treatment of a disabling disorder that currently lacks a clearly effective treatment.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCompulsive Sexual Behavior
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 30, 2007
Enrollment StartMay 1, 2007
Primary CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 19.2 years ago

Interventions

Naltrexonedrug

daily

Sugar pilldrug

daily